Federal grants to Harlingene Life Sciences LLC
Harlingene Life Sciences LLC in Doylestown, Pennsylvania received $1.9 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Allergy and Infectious Diseases Research, with $1.9 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$1.9 million
- Awards3
- Awarded in FY 2025$1.0 million
- Largest award$1.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 1 | $300,000 |
| FY 2023 | 1 | $300,000 |
| FY 2024 | 1 | $300,000 |
| FY 2025 | 1 | $1.0 million |
Programs that fund Harlingene Life Sciences LLC
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $1.9 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $1.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Hepatoselective dihydrozuinolizone (hs-dhq) molecules for treatment and prevention of hepatitis a virus (HAV) infection - abstract this is a phase II proposal to develop harlingene’s hepatoselective dihydroquinolizinones (hs-dhqs) for treatment and prevention of hepatitis a virus (HAV) infection. Th | Allergy and Infectious Diseases Research | August 20, 2025 | $1.0 million |
| Hepatoselective dihydroquinolizinone (hs-dhq) molecules for treatment and prevention of hepatitis a virus (HAV) infection - hepatoselective dihydroquinolizinone (hs-hs-dhq) molecules for treatment and prevention of hepatitis a virus infection abstract this is a phase i proposal to develop harlingene | Allergy and Infectious Diseases Research | April 10, 2023 | $600,000 |
| Developing hepatoselective hepatitis b therapeutic dihydroquinolizinone (DHQ) molecules with better safety profiles for efficient hbsag reduction - abstract inhibition of the host rna quality control enzymes, PAPD5 & 7, with a dihydroquinolizinone rg- 7834 (DHQ-1), a small molecule, rapidly reduces | Allergy and Infectious Diseases Research | June 24, 2022 | $300,000 |
Questions people ask
How much federal grant money does Harlingene Life Sciences LLC get?
$1.9 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Harlingene Life Sciences LLC the most?
The Department of Health and Human Services, with $1.9 million in 3 awards.
What is Harlingene Life Sciences LLC's largest federal grant?
$1.0 million under Allergy and Infectious Diseases Research, with its first action in the period on August 20, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Doylestown
- Bucks, the County of
- Bucks County Intermediate Unit 22
- Fox Chase Chemical Diversity Center Inc.
- Bucks County Housing Authority
- Delaware Valley University
- River Crossing Young Men's Christian Association
- Baruch S. Blumberg Institute
- Evrys Bio, Inc.
Largest federal grant recipients in Pennsylvania · Federal grants in Pennsylvania